Raymed Labs Ltd

Raymed Labs Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Raymed Labs Ltd

₹ 3.48 0.00%
28 Jul - close price
raymedlabs.com BSE: 531207
About

Incorporated in 1994, Raymed Labs Ltd is in
the business of providing ophthalmological products[1]

Key Points

Business Overview:[1]
RMIL manufactures formulations with advanced technologies focusing into Preservative free Ophthalmic dosage for Conjunctivitis and Glaucoma Patient care. It also manufactures other formulations which are converted from suspension to solution. Company has a range of over 80 products. It is a trademark owner of ophthalmic solution (eye drops), antioxidant capsules and tablets. RMIL is also into publication business.

Website BSE
  • Market Cap ₹ 1.49 Cr.
  • Current Price ₹ 3.48
  • High / Low ₹ 3.48 / 2.62
  • Stock P/E
  • Book Value ₹ -6.06
  • Dividend Yield 0.00 %
  • ROCE %
  • ROE %
  • Face Value ₹ 10.0
Edit ratios

Pros

Cons

  • Company has low interest coverage ratio.
  • Promoter holding is low: 32.3%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
0.04 0.05 0.02 0.02 0.10 0.01 0.02 0.02 0.05 0.02 0.02 0.26 0.34
Operating Profit -0.04 -0.05 -0.02 -0.02 -0.10 -0.01 -0.02 -0.02 -0.05 -0.02 -0.02 -0.26 -0.34
OPM %
0.00 0.00 0.00 0.00 0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.52
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.11
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Profit before tax -0.04 -0.05 -0.02 -0.02 -0.08 -0.01 -0.02 -0.02 -0.05 -0.02 -0.02 -0.25 0.07
Tax % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
-0.04 -0.05 -0.02 -0.02 -0.08 -0.02 -0.02 -0.02 -0.05 -0.02 -0.02 -0.25 0.07
EPS in Rs -0.09 -0.12 -0.05 -0.05 -0.19 -0.05 -0.05 -0.05 -0.12 -0.05 -0.05 -0.59 0.16
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
0.03 0.04 0.03 0.03 0.03 0.03 0.06 0.07 0.08 0.19 0.10 0.60
Operating Profit -0.03 -0.04 -0.03 -0.03 -0.03 -0.03 -0.06 -0.07 -0.08 -0.19 -0.10 -0.60
OPM %
-0.02 0.02 0.00 -0.01 -0.02 -0.02 0.01 0.01 0.00 0.02 0.00 0.53
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.11
Depreciation 0.00 0.00 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00
Profit before tax -0.05 -0.02 -0.04 -0.05 -0.06 -0.06 -0.06 -0.07 -0.09 -0.18 -0.10 -0.18
Tax % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
-0.05 -0.02 -0.04 -0.05 -0.06 -0.05 -0.06 -0.07 -0.08 -0.17 -0.10 -0.18
EPS in Rs -0.12 -0.05 -0.09 -0.12 -0.14 -0.12 -0.14 -0.16 -0.19 -0.40 -0.23 -0.42
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: %
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -80%
Stock Price CAGR
10 Years: 3%
5 Years: %
3 Years: 26%
1 Year: 39%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: %

Balance Sheet

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 4.27 4.27 4.27 4.27 4.27 4.27 4.27 4.27 4.27 4.27 4.27 4.27
Reserves -5.99 -6.00 -6.04 -6.09 -6.15 -6.20 -6.26 -6.33 -6.41 -6.58 -6.68 -6.86
1.96 2.00 1.99 2.03 2.04 2.05 2.07 2.21 0.05 0.00 0.00 2.37
0.06 0.04 0.06 0.07 0.11 0.14 0.18 0.10 2.33 2.47 2.56 0.25
Total Liabilities 0.30 0.31 0.28 0.28 0.27 0.26 0.26 0.25 0.24 0.16 0.15 0.03
0.20 0.20 0.19 0.19 0.18 0.17 0.17 0.16 0.16 0.15 0.15 0.00
CWIP 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
0.10 0.11 0.09 0.09 0.09 0.09 0.09 0.09 0.08 0.01 0.00 0.03
Total Assets 0.30 0.31 0.28 0.28 0.27 0.26 0.26 0.25 0.24 0.16 0.15 0.03

Cash Flows

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
0.11 -0.03 0.01 0.00 0.00 0.00 0.00 0.00 -2.21 -0.16 -0.06 -0.59
0.03 0.00 0.00 0.00 0.00 0.00 0.00 0.00 2.21 0.16 0.06 0.59
-0.17 0.03 -0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Cash Flow -0.03 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Ratios

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days
Inventory Days
Days Payable
Cash Conversion Cycle
Working Capital Days
ROCE % -2.78% -7.84% -8.16% -13.95% -16.22% -21.43% -60.00% -60.87%

Shareholding Pattern

Numbers in percentages

Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025
28.36% 28.36% 28.36% 28.36% 28.36% 28.36% 28.36% 28.36% 28.36% 28.36% 32.27% 32.27%
0.96% 0.96% 0.96% 0.96% 0.96% 0.96% 0.96% 0.96% 0.96% 0.96% 0.96% 0.96%
70.69% 70.69% 70.69% 70.68% 70.69% 70.69% 70.68% 70.69% 70.69% 70.69% 66.78% 66.78%
No. of Shareholders 1,4741,4991,5141,5091,5051,4981,5041,5031,4971,4941,4901,490

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports